DX Deals

Amazon Already Making a Mark on Direct-to-Consumer COVID-19 Test Market

Will Amazon transform diagnostic lab testing the way it did the retail industry? Probably not. But the tech giant with the proven capacity to reach into the home and change the shopping patterns of … [Read more...]

M&A Report

23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition

M&A deal making in the diagnostics space remained hot and heavy in June. Key deals included Danaher’s announced $9.6 billion acquisition of life sciences plasma DNA maker Aldevron and the closing … [Read more...]

M&A Report

PerkinElmer Turns COVID Cash into Acquisitions While Myriad Genetics Keeps Divesting

After a frantic month marked by an unusually high number of blockbusters, M&A deal making was relatively slow in May in terms of both deal volume and value. Still, the pace of strategic M&A … [Read more...]

DX Deals

Labs Cutting Deals to Provide Pooled COVID-19 Testing for Schools

As schools return to in-person learning environments, communities across the country are turning to COVID-19 testing programs to monitor and contain the virus. Although, more and more teachers, … [Read more...]

M&A Report

Thermo Fisher, Siemens Healthineers and DiaSorin Headline a Super Dynamic Month in Deal Making

After a prolonged pandemic-induced lull, M&A deal making in the diagnostics market continued its resurgence in April. Here’s a review of what was clearly the most dynamic month in M&A since … [Read more...]

DX Deals

Eurofins Teams with Uber for Home Delivery of COVID-19 Test Kits

At-home COVID-19 testing and sample collection is becoming so big that it’s drawing players from outside the lab testing market. And it’s not just the Walgreens, Walmarts, Amazons and other retailers … [Read more...]

Industry Buzz

Antitrust Regulators Derail Plans for Illumina-Grail Cancer Genomics Powerhouse

You could almost hear the gasp from the cancer genomics market when Illumina announced plans to shell out $8 billion--$3.5 billion in cash and $4.5 billion in common shares—to re-acquire Grail, the … [Read more...]

DX Deals

Abbott Lands $255 Million Rapid COVID-19 Antigen Test Pentagon Contract

In invoking the Defense Production Act (DPA), the Biden Administration has authorized the federal government to mobilize private industry in the war against coronavirus. The administration is also … [Read more...]

M&A Report

M&A Report: Roche Merges with GenMark Diagnostics to Create Syndromic Testing Powerhouse

After a slow start to the year, M&A activity in the diagnostics space accelerated noticeably in March, both in terms of deal volume and impact. The highlight of the month was the March 15 … [Read more...]

M&A Report

Investors Skeptical of Qiagen-Quidel Merger but Believe GenMark Diagnostics Acquisition Rumor

With pandemic pain slowly residing and lab companies awash in COVID-19 testing revenues, it’s not surprising that the M&A cauldron is heating up. While volume has yet to rebound to pre-pandemic … [Read more...]